VRK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O14920 | S177 | GPS6|PSP | IKBKB IKKB | EQRLIHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQ |
| O14920 | S181 | GPS6|PSP | IKBKB IKKB | IHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQKyTV |
| O75531 | S4 | GPS6|SIGNOR|EPSD|PSP | BANF1 BAF BCRG1 | _________________MttsQKHRDFVAEPMGEKPVGSLA |
| O75531 | T2 | GPS6|SIGNOR|EPSD|PSP | BANF1 BAF BCRG1 | ___________________MttsQKHRDFVAEPMGEKPVGS |
| O75531 | T3 | GPS6|SIGNOR|EPSD|PSP | BANF1 BAF BCRG1 | __________________MttsQKHRDFVAEPMGEKPVGSL |
| P04406 | S151 | SIGNOR | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04637 | T18 | GPS6 | TP53 P53 | ___MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S86 | Sugiyama | HSPB1 HSP27 HSP28 | PAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAP |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P10809 | T117 | Sugiyama | HSPD1 HSP60 | LVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISKGANP |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P29401 | T287 | SIGNOR | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P35579 | Y9 | Sugiyama | MYH9 | ____________MAQQAADKyLyVDKNFINNPLAQADWAAK |
| P38432 | S184 | EPSD|PSP | COIL CLN80 | RKNKATCGTVGDDNEEAKRKsPKKKEKCEYKKKAKNPKsPK |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P53350 | T210 | PSP | PLK1 PLK | VKIGDFGLATKVEYDGERKKtLCGtPNyIAPEVLSKKGHSF |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62424 | T93 | Sugiyama | RPL7A SURF-3 SURF3 | RLKVPPAINQFtQALDRQTAtQLLKLAHKYRPEtKQEKKQR |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q13469 | S31 | SIGNOR | NFATC2 NFAT1 NFATP | DGGDAPGHEPGGSPQDELDFsILFDYEYLNPNEEEPNAHKV |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q86Y07 | S190 | Sugiyama | VRK2 | ANLLLGYKNPDQVYLADYGLsYRYCPNGNHKQYQENPRKGH |
| Q86Y07 | S218 | Sugiyama | VRK2 | NHKQYQENPRKGHNGTIEFTsLDAHKGVALSRRSDVEILGY |
| Q86Y07 | S339 | Sugiyama | VRK2 | PLGPLDFSTKGQSINVHtPNsQKVDSQKAATKQVNKAHNRL |
| Q86Y07 | T397 | Sugiyama | VRK2 | KVQKEEKLIGLMNNEAAQEstRRRQKyQEsQEPLNEVNSFP |
| Q86Y07 | Y403 | Sugiyama | VRK2 | KLIGLMNNEAAQEstRRRQKyQEsQEPLNEVNSFPQKISYT |
| Q8IWS0 | T358 | Sugiyama | PHF6 CENP-31 KIAA1823 | EDEERESKsRGKVEIDQQQLtQQQLNGN_____________ |
| Q96EV8 | S297 | SIGNOR|PSP | DTNBP1 BLOC1S8 My031 | CQNEITLQVPNPSELRAKPPssssTCTDSATRDIsEGGEsP |
| Q96EV8 | S299 | SIGNOR|PSP | DTNBP1 BLOC1S8 My031 | NEITLQVPNPSELRAKPPssssTCTDSATRDIsEGGEsPVV |
| Q9UHP3 | S745 | SIGNOR|EPSD|PSP | USP25 USP21 | SEtSVTTAQAAGDPEyLEQPsRSDFSKHLKEETIQIITKAS |
| Q9UHP3 | T680 | SIGNOR|EPSD|PSP | USP25 USP21 | QFLIQEEFNKETGQPLVGIEtLPPDLRDFVEEDNQRFEKEL |
| Q9UHP3 | T727 | SIGNOR|EPSD|PSP | USP25 USP21 | LAQKALQEKLLASQKLRESEtSVTTAQAAGDPEyLEQPsRS |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 0.000001 | 5.852 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 0.000001 | 5.906 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 0.000007 | 5.164 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 0.000084 | 4.075 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 0.000083 | 4.080 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 0.000194 | 3.711 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 0.000252 | 3.598 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 0.000329 | 3.483 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 0.000491 | 3.309 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 0.000482 | 3.317 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 0.001019 | 2.992 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 0.001520 | 2.818 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 0.001889 | 2.724 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 0.002768 | 2.558 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 0.003612 | 2.442 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 0.003612 | 2.442 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 0.003612 | 2.442 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 0.003612 | 2.442 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 0.003612 | 2.442 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 0.003655 | 2.437 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 0.003806 | 2.420 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 0.004403 | 2.356 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 0.005144 | 2.289 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 0.005799 | 2.237 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 0.006887 | 2.162 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 0.007230 | 2.141 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 0.007775 | 2.109 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 0.007570 | 2.121 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 0.008074 | 2.093 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 0.008373 | 2.077 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 0.008348 | 2.078 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 0.009067 | 2.043 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 0.010301 | 1.987 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 0.010144 | 1.994 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 0.010209 | 1.991 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 0.011308 | 1.947 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 0.011239 | 1.949 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 0.012538 | 1.902 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 0.012538 | 1.902 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 0.012105 | 1.917 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 0.012105 | 1.917 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 0.011801 | 1.928 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 0.012107 | 1.917 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 0.013641 | 1.865 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 0.013920 | 1.856 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 0.014190 | 1.848 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 0.013777 | 1.861 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 0.014190 | 1.848 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 0.016914 | 1.772 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 0.015974 | 1.797 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 0.015974 | 1.797 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 0.016340 | 1.787 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 0.016346 | 1.787 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 0.016822 | 1.774 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 0.016734 | 1.776 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 0.014542 | 1.837 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 0.017526 | 1.756 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 0.017526 | 1.756 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 0.018568 | 1.731 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 0.017635 | 1.754 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 0.018289 | 1.738 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 0.018618 | 1.730 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 0.018618 | 1.730 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 0.020712 | 1.684 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 0.020124 | 1.696 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 0.019656 | 1.707 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 0.022244 | 1.653 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 0.024640 | 1.608 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 0.024640 | 1.608 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 0.024187 | 1.616 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 0.024623 | 1.609 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 0.024623 | 1.609 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 0.024350 | 1.613 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 0.024187 | 1.616 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 0.024350 | 1.613 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 0.024231 | 1.616 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 0.025231 | 1.598 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 0.026048 | 1.584 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 0.026076 | 1.584 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 0.026498 | 1.577 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 0.027957 | 1.554 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 0.028545 | 1.544 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 0.028545 | 1.544 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 0.029085 | 1.536 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 0.029460 | 1.531 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 0.034123 | 1.467 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 0.029912 | 1.524 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 0.033301 | 1.478 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 0.033301 | 1.478 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 0.033301 | 1.478 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 0.030001 | 1.523 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 0.033301 | 1.478 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 0.034400 | 1.463 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 0.029912 | 1.524 | 0 | 0 |
| M Phase | R-HSA-68886 | 0.034861 | 1.458 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 0.032795 | 1.484 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 0.033974 | 1.469 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 0.030842 | 1.511 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 0.034123 | 1.467 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 0.032106 | 1.493 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 0.030645 | 1.514 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 0.042837 | 1.368 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 0.042837 | 1.368 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 0.042837 | 1.368 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 0.042837 | 1.368 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 0.039661 | 1.402 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 0.039064 | 1.408 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 0.039661 | 1.402 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 0.037936 | 1.421 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 0.038350 | 1.416 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 0.035916 | 1.445 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 0.039064 | 1.408 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 0.038350 | 1.416 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 0.038591 | 1.414 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 0.039976 | 1.398 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 0.040605 | 1.391 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 0.038362 | 1.416 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 0.037936 | 1.421 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 0.036357 | 1.439 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 0.040337 | 1.394 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 0.039497 | 1.403 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 0.042248 | 1.374 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 0.038917 | 1.410 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 0.035845 | 1.446 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 0.038591 | 1.414 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 0.035922 | 1.445 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 0.042587 | 1.371 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 0.043204 | 1.364 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 0.045624 | 1.341 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 0.048692 | 1.313 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 0.048847 | 1.311 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 0.047480 | 1.323 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 0.048692 | 1.313 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 0.048692 | 1.313 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 0.046015 | 1.337 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 0.048532 | 1.314 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 0.048847 | 1.311 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 0.048692 | 1.313 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 0.048692 | 1.313 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 0.045307 | 1.344 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 0.046015 | 1.337 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 0.045307 | 1.344 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 0.048847 | 1.311 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 0.049750 | 1.303 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 0.050702 | 1.295 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 0.052004 | 1.284 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 0.052004 | 1.284 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 0.059912 | 1.222 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 0.054054 | 1.267 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 0.058667 | 1.232 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 0.053608 | 1.271 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 0.053608 | 1.271 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 0.053608 | 1.271 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 0.053657 | 1.270 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 0.057737 | 1.239 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 0.057737 | 1.239 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 0.054980 | 1.260 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 0.053657 | 1.270 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 0.060620 | 1.217 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 0.056101 | 1.251 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 0.061991 | 1.208 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 0.061991 | 1.208 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 0.083842 | 1.077 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 0.083842 | 1.077 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 0.123093 | 0.910 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 0.123093 | 0.910 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 0.123093 | 0.910 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 0.123093 | 0.910 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 0.123093 | 0.910 | 0 | 0 |
| Defective ALG1 causes CDG-1k | R-HSA-4549380 | 0.123093 | 0.910 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 0.123093 | 0.910 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 0.123093 | 0.910 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 0.160664 | 0.794 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 0.160664 | 0.794 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 0.160664 | 0.794 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 0.160664 | 0.794 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 0.160664 | 0.794 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 0.160664 | 0.794 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 0.160664 | 0.794 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 0.160664 | 0.794 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 0.160664 | 0.794 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 0.160664 | 0.794 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 0.160664 | 0.794 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 0.071918 | 1.143 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 0.071918 | 1.143 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 0.071918 | 1.143 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 0.196628 | 0.706 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 0.196628 | 0.706 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 0.196628 | 0.706 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 0.084620 | 1.073 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 0.097937 | 1.009 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 0.231053 | 0.636 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 0.231053 | 0.636 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 0.231053 | 0.636 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 0.231053 | 0.636 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 0.231053 | 0.636 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 0.231053 | 0.636 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 0.126121 | 0.899 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 0.126121 | 0.899 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 0.264004 | 0.578 | 0 | 0 |
| IRS activation | R-HSA-74713 | 0.264004 | 0.578 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 0.264004 | 0.578 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 0.073528 | 1.134 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 0.140851 | 0.851 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 0.081454 | 1.089 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 0.155924 | 0.807 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 0.155924 | 0.807 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 0.295546 | 0.529 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 0.295546 | 0.529 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 0.295546 | 0.529 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 0.295546 | 0.529 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 0.171283 | 0.766 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 0.107271 | 0.970 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 0.107271 | 0.970 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 0.116503 | 0.934 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 0.325738 | 0.487 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 0.325738 | 0.487 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 0.202657 | 0.693 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 0.066416 | 1.178 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 0.145840 | 0.836 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 0.218579 | 0.660 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 0.218579 | 0.660 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 0.218579 | 0.660 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 0.218579 | 0.660 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 0.218579 | 0.660 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 0.354637 | 0.450 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 0.354637 | 0.450 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 0.354637 | 0.450 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 0.354637 | 0.450 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 0.354637 | 0.450 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 0.354637 | 0.450 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 0.354637 | 0.450 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 0.354637 | 0.450 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 0.177280 | 0.751 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 0.250688 | 0.601 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 0.382300 | 0.418 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 0.382300 | 0.418 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 0.382300 | 0.418 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 0.188147 | 0.726 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 0.188147 | 0.726 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 0.188147 | 0.726 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 0.068419 | 1.165 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 0.199180 | 0.701 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 0.199180 | 0.701 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 0.153178 | 0.815 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 0.210363 | 0.677 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 0.210363 | 0.677 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 0.282912 | 0.548 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 0.408778 | 0.389 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 0.408778 | 0.389 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 0.408778 | 0.389 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 0.104485 | 0.981 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 0.169741 | 0.770 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 0.298989 | 0.524 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 0.298989 | 0.524 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 0.145498 | 0.837 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 0.233113 | 0.632 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 0.103959 | 0.983 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 0.315007 | 0.502 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 0.315007 | 0.502 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 0.434123 | 0.362 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 0.434123 | 0.362 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 0.434123 | 0.362 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 0.434123 | 0.362 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 0.166159 | 0.779 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 0.166159 | 0.779 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 0.256274 | 0.591 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 0.330941 | 0.480 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 0.330941 | 0.480 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 0.330941 | 0.480 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 0.180540 | 0.743 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 0.267972 | 0.572 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 0.267972 | 0.572 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 0.346769 | 0.460 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 0.158448 | 0.800 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 0.362470 | 0.441 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 0.362470 | 0.441 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 0.362470 | 0.441 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 0.362470 | 0.441 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 0.155443 | 0.808 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 0.378027 | 0.422 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 0.378027 | 0.422 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 0.181075 | 0.742 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 0.181075 | 0.742 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 0.288963 | 0.539 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 0.338957 | 0.470 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 0.338957 | 0.470 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 0.308411 | 0.511 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 0.350807 | 0.455 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 0.362632 | 0.441 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 0.362632 | 0.441 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 0.362632 | 0.441 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 0.423675 | 0.373 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 0.423675 | 0.373 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 0.423675 | 0.373 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 0.386170 | 0.413 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 0.275343 | 0.560 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 0.275343 | 0.560 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 0.321077 | 0.493 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 0.409497 | 0.388 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 0.379245 | 0.421 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 0.119951 | 0.921 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 0.298989 | 0.524 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 0.127296 | 0.895 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 0.210363 | 0.677 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 0.091091 | 1.041 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 0.298989 | 0.524 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 0.315007 | 0.502 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 0.374745 | 0.426 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 0.338957 | 0.470 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 0.338957 | 0.470 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 0.111795 | 0.952 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 0.098341 | 1.007 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 0.354637 | 0.450 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 0.210363 | 0.677 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 0.393758 | 0.405 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 0.253871 | 0.595 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 0.253871 | 0.595 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 0.253871 | 0.595 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 0.171283 | 0.766 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 0.129582 | 0.887 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 0.117664 | 0.929 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 0.214059 | 0.669 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 0.152257 | 0.817 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 0.323769 | 0.490 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 0.084620 | 1.073 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 0.202657 | 0.693 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 0.188147 | 0.726 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 0.064997 | 1.187 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 0.434123 | 0.362 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 0.434123 | 0.362 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 0.330941 | 0.480 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 0.315228 | 0.501 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 0.327094 | 0.485 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 0.338957 | 0.470 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 0.419391 | 0.377 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 0.126020 | 0.900 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 0.233113 | 0.632 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 0.214059 | 0.669 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 0.076929 | 1.114 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 0.397864 | 0.400 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 0.290919 | 0.536 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 0.248895 | 0.604 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 0.248895 | 0.604 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 0.155924 | 0.807 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 0.094070 | 1.027 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 0.234602 | 0.630 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 0.122079 | 0.913 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 0.382300 | 0.418 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 0.330941 | 0.480 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 0.336461 | 0.473 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 0.089730 | 1.047 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 0.155924 | 0.807 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 0.116503 | 0.934 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 0.081200 | 1.090 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 0.081200 | 1.090 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 0.081200 | 1.090 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 0.081200 | 1.090 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 0.393423 | 0.405 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 0.096374 | 1.016 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 0.423675 | 0.373 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 0.085822 | 1.066 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 0.126825 | 0.897 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 0.233113 | 0.632 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 0.102505 | 0.989 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 0.097937 | 1.009 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 0.081454 | 1.089 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 0.186877 | 0.728 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 0.354637 | 0.450 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 0.107661 | 0.968 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 0.129582 | 0.887 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 0.298989 | 0.524 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 0.267972 | 0.572 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 0.241270 | 0.617 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 0.393423 | 0.405 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 0.259508 | 0.586 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 0.386902 | 0.412 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 0.081454 | 1.089 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 0.219769 | 0.658 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 0.171283 | 0.766 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 0.114675 | 0.941 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 0.278695 | 0.555 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 0.385189 | 0.414 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 0.298668 | 0.525 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 0.069596 | 1.157 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 0.378027 | 0.422 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 0.109519 | 0.961 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 0.119951 | 0.921 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 0.097805 | 1.010 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 0.231053 | 0.636 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 0.231053 | 0.636 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 0.186877 | 0.728 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 0.186877 | 0.728 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 0.325738 | 0.487 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 0.166595 | 0.778 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 0.346769 | 0.460 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 0.338957 | 0.470 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 0.276648 | 0.558 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 0.159146 | 0.798 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 0.081200 | 1.090 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 0.160425 | 0.795 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 0.315228 | 0.501 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 0.408644 | 0.389 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 0.408644 | 0.389 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 0.328690 | 0.483 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 0.396686 | 0.402 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 0.267972 | 0.572 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 0.065969 | 1.181 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 0.317494 | 0.498 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 0.132381 | 0.878 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 0.083043 | 1.081 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 0.266802 | 0.574 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 0.195675 | 0.708 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 0.195675 | 0.708 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 0.362632 | 0.441 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 0.218579 | 0.660 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 0.077363 | 1.111 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 0.256407 | 0.591 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 0.220551 | 0.656 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 0.397864 | 0.400 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 0.327094 | 0.485 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 0.160664 | 0.794 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 0.160664 | 0.794 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 0.196628 | 0.706 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 0.097937 | 1.009 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 0.231053 | 0.636 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 0.231053 | 0.636 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 0.155924 | 0.807 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 0.155924 | 0.807 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 0.295546 | 0.529 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 0.295546 | 0.529 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 0.325738 | 0.487 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 0.325738 | 0.487 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 0.202657 | 0.693 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 0.085822 | 1.066 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 0.408778 | 0.389 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 0.434123 | 0.362 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 0.434123 | 0.362 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 0.330941 | 0.480 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 0.077529 | 1.111 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 0.127177 | 0.896 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 0.378027 | 0.422 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 0.393423 | 0.405 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 0.159366 | 0.798 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 0.162889 | 0.788 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 0.198106 | 0.703 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 0.433659 | 0.363 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 0.376613 | 0.424 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 0.191819 | 0.717 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 0.316237 | 0.500 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 0.378416 | 0.422 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 0.214873 | 0.668 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 0.225536 | 0.647 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 0.146917 | 0.833 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 0.279730 | 0.553 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 0.098341 | 1.007 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 0.325738 | 0.487 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 0.282912 | 0.548 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 0.108927 | 0.963 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 0.180818 | 0.743 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 0.085145 | 1.070 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 0.222725 | 0.652 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 0.166230 | 0.779 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 0.166089 | 0.780 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 0.150846 | 0.821 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 0.071918 | 1.143 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 0.097937 | 1.009 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 0.231053 | 0.636 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 0.295546 | 0.529 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 0.354637 | 0.450 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 0.080556 | 1.094 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 0.160204 | 0.795 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 0.133056 | 0.876 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 0.142217 | 0.847 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 0.180540 | 0.743 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 0.064129 | 1.193 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 0.085602 | 1.068 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 0.088466 | 1.053 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 0.393366 | 0.405 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 0.321905 | 0.492 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 0.427897 | 0.369 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 0.336327 | 0.473 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 0.144225 | 0.841 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 0.153178 | 0.815 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 0.153178 | 0.815 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 0.143042 | 0.845 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 0.254145 | 0.595 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 0.200254 | 0.698 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 0.130856 | 0.883 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 0.123093 | 0.910 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 0.196628 | 0.706 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 0.186877 | 0.728 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 0.354637 | 0.450 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 0.354637 | 0.450 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 0.382300 | 0.418 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 0.266802 | 0.574 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 0.090132 | 1.045 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 0.408778 | 0.389 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 0.408778 | 0.389 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 0.244650 | 0.611 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 0.173291 | 0.761 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 0.173291 | 0.761 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 0.187899 | 0.726 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 0.291453 | 0.535 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 0.350891 | 0.455 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 0.421060 | 0.376 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 0.410863 | 0.386 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 0.428637 | 0.368 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 0.305089 | 0.516 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 0.102505 | 0.989 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 0.113821 | 0.944 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 0.334377 | 0.476 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 0.374423 | 0.427 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 0.323775 | 0.490 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 0.122079 | 0.913 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 0.142767 | 0.845 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 0.193321 | 0.714 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 0.091091 | 1.041 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 0.140024 | 0.854 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 0.130856 | 0.883 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 0.201870 | 0.695 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 0.244650 | 0.611 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 0.196628 | 0.706 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 0.325738 | 0.487 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 0.100759 | 0.997 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 0.282912 | 0.548 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 0.186896 | 0.728 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 0.315007 | 0.502 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 0.347623 | 0.459 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 0.089241 | 1.049 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 0.350807 | 0.455 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 0.137363 | 0.862 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 0.250688 | 0.601 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 0.142217 | 0.847 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 0.308411 | 0.511 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 0.428609 | 0.368 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 0.122747 | 0.911 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 0.119875 | 0.921 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 0.196628 | 0.706 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 0.231053 | 0.636 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 0.231053 | 0.636 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 0.264004 | 0.578 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 0.264004 | 0.578 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 0.264004 | 0.578 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 0.354637 | 0.450 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 0.064997 | 1.187 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 0.199180 | 0.701 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 0.408778 | 0.389 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 0.408778 | 0.389 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 0.315007 | 0.502 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 0.362470 | 0.441 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 0.160425 | 0.795 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 0.390162 | 0.409 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 0.156110 | 0.807 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 0.434123 | 0.362 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 0.290304 | 0.537 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 0.171283 | 0.766 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 0.202657 | 0.693 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 0.408778 | 0.389 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 0.066108 | 1.180 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 0.283094 | 0.548 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 0.261212 | 0.583 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 0.305997 | 0.514 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 0.181197 | 0.742 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 0.303370 | 0.518 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 0.414545 | 0.382 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 0.094070 | 1.027 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 0.330941 | 0.480 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 0.126121 | 0.899 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 0.264004 | 0.578 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 0.295546 | 0.529 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 0.325738 | 0.487 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 0.354637 | 0.450 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 0.091091 | 1.041 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 0.145139 | 0.838 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 0.090132 | 1.045 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 0.408778 | 0.389 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 0.408778 | 0.389 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 0.434123 | 0.362 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 0.088466 | 1.053 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 0.402020 | 0.396 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 0.408644 | 0.389 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 0.208406 | 0.681 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 0.080718 | 1.093 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 0.250688 | 0.601 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 0.298989 | 0.524 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 0.199180 | 0.701 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 0.191819 | 0.717 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 0.273468 | 0.563 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 0.118400 | 0.927 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 0.094070 | 1.027 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 0.223287 | 0.651 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 0.302470 | 0.519 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 0.234602 | 0.630 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 0.382300 | 0.418 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 0.298989 | 0.524 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 0.434123 | 0.362 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 0.210848 | 0.676 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 0.403605 | 0.394 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 0.099593 | 1.002 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 0.076258 | 1.118 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 0.126121 | 0.899 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 0.377098 | 0.424 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 0.377098 | 0.424 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 0.219769 | 0.658 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 0.397870 | 0.400 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 0.413268 | 0.384 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 0.295546 | 0.529 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 0.166595 | 0.778 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 0.282912 | 0.548 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 0.434123 | 0.362 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 0.195364 | 0.709 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 0.086533 | 1.063 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 0.298989 | 0.524 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 0.081454 | 1.089 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 0.397864 | 0.400 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 0.254575 | 0.594 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 0.266802 | 0.574 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 0.186896 | 0.728 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 0.162840 | 0.788 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 0.408144 | 0.389 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 0.186877 | 0.728 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 0.354637 | 0.450 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 0.423675 | 0.373 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 0.269697 | 0.569 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 0.308411 | 0.511 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 0.377098 | 0.424 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 0.107661 | 0.968 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 0.143337 | 0.844 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 0.126121 | 0.899 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 0.434123 | 0.362 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 0.423675 | 0.373 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 0.382300 | 0.418 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 0.434123 | 0.362 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 0.421060 | 0.376 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 0.171283 | 0.766 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 0.327094 | 0.485 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 0.250688 | 0.601 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 0.338957 | 0.470 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 0.099575 | 1.002 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 0.079920 | 1.097 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 0.423675 | 0.373 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 0.186877 | 0.728 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 0.408644 | 0.389 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 0.079650 | 1.099 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 0.282912 | 0.548 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 0.362470 | 0.441 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 0.345774 | 0.461 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 0.068419 | 1.165 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 0.396686 | 0.402 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 0.375816 | 0.425 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 0.438506 | 0.358 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 0.438506 | 0.358 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 0.438506 | 0.358 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 0.438506 | 0.358 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 0.438506 | 0.358 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 0.443947 | 0.353 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 0.443947 | 0.353 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 0.444833 | 0.352 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 0.445115 | 0.352 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 0.445941 | 0.351 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 0.453126 | 0.344 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 0.453126 | 0.344 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 0.453126 | 0.344 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 0.453126 | 0.344 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 0.454668 | 0.342 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 0.454668 | 0.342 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 0.458383 | 0.339 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 0.458383 | 0.339 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 0.458383 | 0.339 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 0.458383 | 0.339 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 0.458383 | 0.339 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 0.458383 | 0.339 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 0.458383 | 0.339 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 0.458383 | 0.339 | 0 | 0 |
| Hormone ligand-binding receptors | R-HSA-375281 | 0.458383 | 0.339 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 0.458383 | 0.339 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 0.458383 | 0.339 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 0.458383 | 0.339 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 0.461642 | 0.336 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 0.467299 | 0.330 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 0.467525 | 0.330 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 0.467525 | 0.330 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 0.467525 | 0.330 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 0.467525 | 0.330 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 0.467525 | 0.330 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 0.470337 | 0.328 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 0.473605 | 0.325 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 0.473762 | 0.324 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 0.477579 | 0.321 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 0.477662 | 0.321 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 0.480208 | 0.319 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 0.481604 | 0.317 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 0.481604 | 0.317 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 0.481604 | 0.317 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 0.481604 | 0.317 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 0.481604 | 0.317 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 0.481604 | 0.317 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 0.481604 | 0.317 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 0.481604 | 0.317 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 0.481604 | 0.317 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 0.481604 | 0.317 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 0.481604 | 0.317 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 0.481604 | 0.317 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 0.481604 | 0.317 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 0.481604 | 0.317 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 0.481697 | 0.317 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 0.481697 | 0.317 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 0.482981 | 0.316 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 0.485381 | 0.314 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 0.486564 | 0.313 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 0.486633 | 0.313 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 0.488579 | 0.311 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 0.489214 | 0.311 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 0.492290 | 0.308 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 0.493936 | 0.306 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 0.494782 | 0.306 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 0.494782 | 0.306 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 0.495633 | 0.305 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 0.499419 | 0.302 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 0.499465 | 0.301 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 0.499465 | 0.301 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 0.499465 | 0.301 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 0.501528 | 0.300 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 0.503831 | 0.298 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 0.503831 | 0.298 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 0.503831 | 0.298 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 0.503831 | 0.298 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 0.503831 | 0.298 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 0.503831 | 0.298 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 0.503831 | 0.298 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 0.503831 | 0.298 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 0.503831 | 0.298 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 0.503831 | 0.298 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 0.503831 | 0.298 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 0.503831 | 0.298 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 0.503831 | 0.298 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 0.503831 | 0.298 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 0.503831 | 0.298 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 0.503831 | 0.298 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 0.503831 | 0.298 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 0.503831 | 0.298 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 0.503831 | 0.298 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 0.504057 | 0.298 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 0.504978 | 0.297 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 0.509329 | 0.293 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 0.509329 | 0.293 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 0.509329 | 0.293 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 0.509329 | 0.293 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 0.511067 | 0.292 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 0.518524 | 0.285 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 0.518820 | 0.285 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 0.519779 | 0.284 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 0.522778 | 0.282 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 0.522778 | 0.282 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 0.522778 | 0.282 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 0.523594 | 0.281 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 0.525106 | 0.280 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 0.525106 | 0.280 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 0.525106 | 0.280 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 0.525106 | 0.280 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 0.525106 | 0.280 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 0.525106 | 0.280 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 0.525106 | 0.280 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 0.525106 | 0.280 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 0.528785 | 0.277 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 0.531394 | 0.275 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 0.531394 | 0.275 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 0.535081 | 0.272 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 0.535978 | 0.271 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 0.535978 | 0.271 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 0.535978 | 0.271 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 0.535978 | 0.271 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 0.535978 | 0.271 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 0.535978 | 0.271 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 0.537709 | 0.269 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 0.537709 | 0.269 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 0.542966 | 0.265 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 0.545471 | 0.263 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 0.545471 | 0.263 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 0.545471 | 0.263 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 0.545471 | 0.263 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 0.545471 | 0.263 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 0.545471 | 0.263 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 0.545471 | 0.263 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 0.546546 | 0.262 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 0.548924 | 0.260 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 0.548924 | 0.260 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 0.548924 | 0.260 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 0.549880 | 0.260 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 0.550788 | 0.259 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 0.552033 | 0.258 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 0.553466 | 0.257 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 0.558544 | 0.253 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 0.561615 | 0.251 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 0.561615 | 0.251 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 0.561615 | 0.251 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 0.561615 | 0.251 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 0.561615 | 0.251 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 0.561615 | 0.251 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 0.561615 | 0.251 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 0.561715 | 0.250 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 0.562148 | 0.250 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 0.563953 | 0.249 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 0.564963 | 0.248 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 0.564963 | 0.248 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 0.564963 | 0.248 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 0.564963 | 0.248 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 0.564963 | 0.248 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 0.564963 | 0.248 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 0.564963 | 0.248 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 0.564963 | 0.248 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 0.564963 | 0.248 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 0.564963 | 0.248 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 0.564963 | 0.248 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 0.564963 | 0.248 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 0.564963 | 0.248 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 0.564963 | 0.248 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 0.564963 | 0.248 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 0.564963 | 0.248 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 0.572123 | 0.243 | 0 | 0 |
| Kinesins | R-HSA-983189 | 0.572123 | 0.243 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 0.572518 | 0.242 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 0.574048 | 0.241 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 0.574048 | 0.241 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 0.577631 | 0.238 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 0.581956 | 0.235 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 0.581956 | 0.235 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 0.583620 | 0.234 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 0.583620 | 0.234 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 0.583620 | 0.234 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 0.583620 | 0.234 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 0.583620 | 0.234 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 0.583620 | 0.234 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 0.583620 | 0.234 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 0.583620 | 0.234 | 0 | 0 |
| Mineralocorticoid biosynthesis | R-HSA-193993 | 0.583620 | 0.234 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 0.583620 | 0.234 | 0 | 0 |
| S Phase | R-HSA-69242 | 0.590291 | 0.229 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 0.591645 | 0.228 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 0.596791 | 0.224 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 0.598136 | 0.223 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 0.598136 | 0.223 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 0.598136 | 0.223 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 0.598556 | 0.223 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 0.601187 | 0.221 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 0.601187 | 0.221 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 0.601479 | 0.221 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 0.601479 | 0.221 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 0.601479 | 0.221 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 0.601479 | 0.221 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 0.601479 | 0.221 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 0.601479 | 0.221 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 0.601479 | 0.221 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 0.601479 | 0.221 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 0.601479 | 0.221 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 0.601479 | 0.221 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 0.601479 | 0.221 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 0.603616 | 0.219 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 0.605807 | 0.218 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 0.605807 | 0.218 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 0.609791 | 0.215 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 0.609791 | 0.215 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 0.609791 | 0.215 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 0.609791 | 0.215 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 0.610581 | 0.214 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 0.613878 | 0.212 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 0.615028 | 0.211 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 0.618572 | 0.209 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 0.618572 | 0.209 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 0.618572 | 0.209 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 0.618572 | 0.209 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 0.621186 | 0.207 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 0.621186 | 0.207 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 0.621186 | 0.207 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 0.621186 | 0.207 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 0.621186 | 0.207 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 0.622395 | 0.206 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 0.622523 | 0.206 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 0.625634 | 0.204 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 0.628921 | 0.201 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 0.629711 | 0.201 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 0.632323 | 0.199 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 0.632323 | 0.199 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 0.632323 | 0.199 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 0.632323 | 0.199 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 0.632323 | 0.199 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 0.632323 | 0.199 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 0.632323 | 0.199 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 0.634933 | 0.197 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 0.634933 | 0.197 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 0.634933 | 0.197 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 0.634933 | 0.197 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 0.634933 | 0.197 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 0.634933 | 0.197 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 0.634933 | 0.197 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 0.634933 | 0.197 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 0.637865 | 0.195 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 0.643202 | 0.192 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 0.643202 | 0.192 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 0.643202 | 0.192 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 0.643202 | 0.192 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 0.643202 | 0.192 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 0.646656 | 0.189 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 0.650565 | 0.187 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 0.650594 | 0.187 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 0.650594 | 0.187 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 0.650594 | 0.187 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 0.650594 | 0.187 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 0.650594 | 0.187 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 0.650594 | 0.187 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 0.650594 | 0.187 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 0.650594 | 0.187 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 0.650594 | 0.187 | 0 | 0 |
| Protein folding | R-HSA-391251 | 0.652666 | 0.185 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 0.653825 | 0.185 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 0.653825 | 0.185 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 0.663782 | 0.178 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 0.663782 | 0.178 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 0.664195 | 0.178 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 0.664195 | 0.178 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 0.665583 | 0.177 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 0.665583 | 0.177 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 0.665583 | 0.177 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 0.665583 | 0.177 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 0.665583 | 0.177 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 0.665583 | 0.177 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 0.665583 | 0.177 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 0.665583 | 0.177 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 0.666020 | 0.177 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 0.666676 | 0.176 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 0.666676 | 0.176 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 0.672116 | 0.173 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 0.672116 | 0.173 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 0.672116 | 0.173 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 0.672116 | 0.173 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 0.672116 | 0.173 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 0.672116 | 0.173 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 0.672301 | 0.172 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 0.674313 | 0.171 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 0.674313 | 0.171 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 0.674313 | 0.171 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 0.674313 | 0.171 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 0.674313 | 0.171 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 0.674313 | 0.171 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 0.674313 | 0.171 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 0.674313 | 0.171 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 0.674313 | 0.171 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 0.679931 | 0.168 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 0.679931 | 0.168 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 0.679931 | 0.168 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 0.679931 | 0.168 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 0.679931 | 0.168 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 0.679931 | 0.168 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 0.679931 | 0.168 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 0.682700 | 0.166 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 0.684182 | 0.165 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 0.684182 | 0.165 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 0.688326 | 0.162 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 0.688764 | 0.162 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 0.688764 | 0.162 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 0.691601 | 0.160 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 0.693663 | 0.159 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 0.693663 | 0.159 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 0.693663 | 0.159 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 0.693805 | 0.159 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 0.696187 | 0.157 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 0.696203 | 0.157 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 0.702437 | 0.153 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 0.703184 | 0.153 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 0.703184 | 0.153 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 0.703878 | 0.153 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 0.703928 | 0.152 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 0.703928 | 0.152 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 0.706807 | 0.151 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 0.706807 | 0.151 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 0.706807 | 0.151 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 0.706807 | 0.151 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 0.706807 | 0.151 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 0.706807 | 0.151 | 0 | 0 |
| Reactions specific to the complex N-glycan synthesis pathway | R-HSA-975578 | 0.706807 | 0.151 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 0.706807 | 0.151 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 0.709109 | 0.149 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 0.711502 | 0.148 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 0.712323 | 0.147 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 0.712323 | 0.147 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 0.712323 | 0.147 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 0.719388 | 0.143 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 0.719388 | 0.143 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 0.719388 | 0.143 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 0.719388 | 0.143 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 0.719388 | 0.143 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 0.719388 | 0.143 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 0.721225 | 0.142 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 0.725487 | 0.139 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 0.726202 | 0.139 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 0.726202 | 0.139 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 0.729893 | 0.137 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 0.731430 | 0.136 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 0.731430 | 0.136 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 0.731430 | 0.136 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 0.731430 | 0.136 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 0.731430 | 0.136 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 0.731430 | 0.136 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 0.731430 | 0.136 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 0.731430 | 0.136 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 0.733068 | 0.135 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 0.733068 | 0.135 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 0.733068 | 0.135 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 0.738332 | 0.132 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 0.738332 | 0.132 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 0.738332 | 0.132 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 0.738332 | 0.132 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 0.738332 | 0.132 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 0.738682 | 0.132 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 0.740308 | 0.131 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 0.742956 | 0.129 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 0.742956 | 0.129 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 0.742956 | 0.129 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 0.742956 | 0.129 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 0.742956 | 0.129 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 0.742956 | 0.129 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 0.742956 | 0.129 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 0.743753 | 0.129 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 0.743777 | 0.129 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 0.744141 | 0.128 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 0.746545 | 0.127 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 0.746545 | 0.127 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 0.752762 | 0.123 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 0.753988 | 0.123 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 0.753988 | 0.123 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 0.753988 | 0.123 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 0.753988 | 0.123 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 0.754535 | 0.122 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 0.754535 | 0.122 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 0.755269 | 0.122 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 0.760111 | 0.119 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 0.762308 | 0.118 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 0.764547 | 0.117 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 0.764547 | 0.117 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 0.764547 | 0.117 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 0.764547 | 0.117 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 0.764547 | 0.117 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 0.764547 | 0.117 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 0.764547 | 0.117 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 0.764547 | 0.117 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 0.764547 | 0.117 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 0.764547 | 0.117 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 0.765265 | 0.116 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 0.766784 | 0.115 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 0.769866 | 0.114 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 0.769866 | 0.114 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 0.769866 | 0.114 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 0.773012 | 0.112 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 0.774654 | 0.111 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 0.774654 | 0.111 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 0.777213 | 0.109 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 0.777271 | 0.109 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 0.779175 | 0.108 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 0.780223 | 0.108 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 0.783004 | 0.106 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 0.784327 | 0.106 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 0.784327 | 0.106 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 0.784327 | 0.106 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 0.784327 | 0.106 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 0.784327 | 0.106 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 0.784327 | 0.106 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 0.784327 | 0.106 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 0.784355 | 0.105 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 0.785165 | 0.105 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 0.791199 | 0.102 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 0.791295 | 0.102 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 0.793585 | 0.100 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 0.793585 | 0.100 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 0.793585 | 0.100 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 0.793585 | 0.100 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 0.793585 | 0.100 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 0.796742 | 0.099 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 0.798037 | 0.098 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 0.798037 | 0.098 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 0.802447 | 0.096 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 0.802447 | 0.096 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 0.802447 | 0.096 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 0.802447 | 0.096 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 0.802447 | 0.096 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 0.802447 | 0.096 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 0.802447 | 0.096 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 0.802447 | 0.096 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 0.802447 | 0.096 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 0.802447 | 0.096 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 0.807385 | 0.093 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 0.807792 | 0.093 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 0.808336 | 0.092 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 0.810929 | 0.091 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 0.810929 | 0.091 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 0.810929 | 0.091 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 0.810944 | 0.091 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 0.810944 | 0.091 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 0.810944 | 0.091 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 0.810944 | 0.091 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 0.817118 | 0.088 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 0.817118 | 0.088 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 0.819047 | 0.087 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 0.819047 | 0.087 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 0.819047 | 0.087 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 0.819047 | 0.087 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 0.819280 | 0.087 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 0.823111 | 0.085 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 0.824697 | 0.084 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 0.826817 | 0.083 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 0.826817 | 0.083 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 0.826817 | 0.083 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 0.826817 | 0.083 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 0.826817 | 0.083 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 0.826817 | 0.083 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 0.826817 | 0.083 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 0.828927 | 0.081 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 0.829100 | 0.081 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 0.833219 | 0.079 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 0.834254 | 0.079 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 0.834254 | 0.079 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 0.834254 | 0.079 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 0.834254 | 0.079 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 0.834254 | 0.079 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 0.834254 | 0.079 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 0.834254 | 0.079 | 0 | 0 |
| Immune System | R-HSA-168256 | 0.834552 | 0.079 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 0.839689 | 0.076 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 0.841371 | 0.075 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 0.841371 | 0.075 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 0.841371 | 0.075 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 0.841760 | 0.075 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 0.845354 | 0.073 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 0.847044 | 0.072 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 0.848184 | 0.072 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 0.848184 | 0.072 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 0.848184 | 0.072 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 0.848184 | 0.072 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 0.848184 | 0.072 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 0.848184 | 0.072 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 0.848184 | 0.072 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 0.849755 | 0.071 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 0.851427 | 0.070 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 0.854705 | 0.068 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 0.854705 | 0.068 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 0.854705 | 0.068 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 0.854705 | 0.068 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 0.854705 | 0.068 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 0.854705 | 0.068 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 0.854705 | 0.068 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 0.854705 | 0.068 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 0.855496 | 0.068 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 0.855699 | 0.068 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 0.860336 | 0.065 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 0.860336 | 0.065 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 0.860945 | 0.065 | 0 | 0 |
| Depurination | R-HSA-73927 | 0.860945 | 0.065 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 0.860945 | 0.065 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 0.860945 | 0.065 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 0.860945 | 0.065 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 0.866918 | 0.062 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 0.866918 | 0.062 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 0.866918 | 0.062 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 0.866918 | 0.062 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 0.866918 | 0.062 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 0.871121 | 0.060 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 0.871732 | 0.060 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 0.872635 | 0.059 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 0.872635 | 0.059 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 0.872635 | 0.059 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 0.872635 | 0.059 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 0.872635 | 0.059 | 0 | 0 |
| N-glycan antennae elongation in the medial/trans-Golgi | R-HSA-975576 | 0.872635 | 0.059 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 0.878107 | 0.056 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 0.878107 | 0.056 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 0.878107 | 0.056 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 0.878247 | 0.056 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 0.879142 | 0.056 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 0.881237 | 0.055 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 0.881237 | 0.055 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 0.882381 | 0.054 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 0.883344 | 0.054 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 0.883344 | 0.054 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 0.883344 | 0.054 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 0.883556 | 0.054 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 0.886385 | 0.052 | 0 | 0 |
| Translation | R-HSA-72766 | 0.886435 | 0.052 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 0.887849 | 0.052 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 0.888356 | 0.051 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 0.888356 | 0.051 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 0.888356 | 0.051 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 0.889544 | 0.051 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 0.890263 | 0.050 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 0.893153 | 0.049 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 0.893153 | 0.049 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 0.893153 | 0.049 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 0.897744 | 0.047 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 0.897744 | 0.047 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 0.897744 | 0.047 | 0 | 0 |
| Methylation | R-HSA-156581 | 0.897744 | 0.047 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 0.897744 | 0.047 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 0.899139 | 0.046 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 0.902138 | 0.045 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 0.902138 | 0.045 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 0.902138 | 0.045 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 0.904576 | 0.044 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 0.905111 | 0.043 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 0.906344 | 0.043 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 0.906344 | 0.043 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 0.906344 | 0.043 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 0.906344 | 0.043 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 0.907871 | 0.042 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 0.910369 | 0.041 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 0.910369 | 0.041 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 0.910369 | 0.041 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 0.910369 | 0.041 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 0.911698 | 0.040 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 0.914145 | 0.039 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 0.914222 | 0.039 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 0.916107 | 0.038 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 0.916295 | 0.038 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 0.917077 | 0.038 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 0.917909 | 0.037 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 0.917909 | 0.037 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 0.917909 | 0.037 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 0.920016 | 0.036 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 0.921438 | 0.036 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 0.921438 | 0.036 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 0.921438 | 0.036 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 0.924815 | 0.034 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 0.924815 | 0.034 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 0.928047 | 0.032 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 0.928047 | 0.032 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 0.928047 | 0.032 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 0.930173 | 0.031 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 0.930184 | 0.031 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 0.930643 | 0.031 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 0.931141 | 0.031 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 0.931141 | 0.031 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 0.934102 | 0.030 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 0.936935 | 0.028 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 0.936935 | 0.028 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 0.937723 | 0.028 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 0.937723 | 0.028 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 0.939289 | 0.027 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 0.939647 | 0.027 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 0.939647 | 0.027 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 0.939647 | 0.027 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 0.939926 | 0.027 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 0.939926 | 0.027 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 0.942055 | 0.026 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 0.942226 | 0.026 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 0.942242 | 0.026 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 0.942242 | 0.026 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 0.942242 | 0.026 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 0.944113 | 0.025 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 0.947024 | 0.024 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 0.947104 | 0.024 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 0.947104 | 0.024 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 0.948021 | 0.023 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 0.949379 | 0.023 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 0.949379 | 0.023 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 0.949379 | 0.023 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 0.951556 | 0.022 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 0.951556 | 0.022 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 0.951556 | 0.022 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 0.951556 | 0.022 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 0.951556 | 0.022 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 0.952281 | 0.021 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 0.953381 | 0.021 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 0.953640 | 0.021 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 0.955070 | 0.020 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 0.955635 | 0.020 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 0.959370 | 0.018 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 0.962792 | 0.016 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 0.962792 | 0.016 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 0.962792 | 0.016 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 0.962792 | 0.016 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 0.962792 | 0.016 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 0.963468 | 0.016 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 0.964316 | 0.016 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 0.964393 | 0.016 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 0.964393 | 0.016 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 0.964393 | 0.016 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 0.964868 | 0.016 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 0.965925 | 0.015 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 0.966522 | 0.015 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 0.966610 | 0.015 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 0.967392 | 0.014 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 0.968582 | 0.014 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 0.968582 | 0.014 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 0.968795 | 0.014 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 0.968795 | 0.014 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 0.970046 | 0.013 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 0.970138 | 0.013 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 0.970138 | 0.013 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 0.971424 | 0.013 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 0.971424 | 0.013 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 0.973831 | 0.012 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 0.973831 | 0.012 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 0.973831 | 0.012 | 0 | 0 |
| Disease | R-HSA-1643685 | 0.974372 | 0.011 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 0.976933 | 0.010 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 0.977068 | 0.010 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 0.978056 | 0.010 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 0.979001 | 0.009 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 0.979988 | 0.009 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 0.982391 | 0.008 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 0.982934 | 0.007 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 0.984179 | 0.007 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 0.984581 | 0.007 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 0.985235 | 0.006 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 0.985516 | 0.006 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 0.985872 | 0.006 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 0.986918 | 0.006 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 0.987063 | 0.006 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 0.987386 | 0.006 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 0.987741 | 0.005 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 0.987762 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 0.988665 | 0.005 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 0.989153 | 0.005 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 0.989194 | 0.005 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 0.989621 | 0.005 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 0.990414 | 0.004 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 0.990496 | 0.004 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 0.990906 | 0.004 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 0.991081 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 0.991674 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 0.992033 | 0.003 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 0.993101 | 0.003 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 0.993609 | 0.003 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 0.993609 | 0.003 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 0.993701 | 0.003 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 0.993760 | 0.003 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 0.994351 | 0.002 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 0.994401 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 0.994688 | 0.002 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 0.995167 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 0.995307 | 0.002 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 0.996066 | 0.002 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 0.996236 | 0.002 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 0.996351 | 0.002 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 0.996416 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 0.996554 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 0.997901 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 0.997971 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 0.998288 | 0.001 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 0.998343 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 0.998511 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 0.998543 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 0.998805 | 0.001 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 0.999089 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 0.999198 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 0.999385 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 0.999437 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 0.999437 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 0.999529 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 0.999549 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 0.999696 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 0.999707 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 0.999810 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 0.999837 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 0.999902 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 0.999936 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 0.999944 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 0.999971 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 0.999972 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 0.999983 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 0.999989 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 0.999998 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 0.999999 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.740198e-08 | 7.759 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.116684e-08 | 7.291 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.599248e-07 | 6.252 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.579969e-07 | 6.019 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.101158e-06 | 5.958 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.194898e-07 | 6.086 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.101158e-06 | 5.958 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.288104e-06 | 5.890 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.165750e-06 | 5.500 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.189577e-06 | 5.496 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.478947e-06 | 5.349 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.329715e-06 | 5.135 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.404665e-05 | 4.852 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.553863e-05 | 4.809 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.869110e-05 | 4.728 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.036426e-05 | 4.691 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.614910e-05 | 4.583 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.833046e-05 | 4.548 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.026539e-05 | 4.519 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.741407e-05 | 4.324 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.847458e-05 | 4.314 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.689298e-05 | 4.329 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.689298e-05 | 4.329 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.432942e-05 | 4.353 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.432942e-05 | 4.353 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.763552e-05 | 4.424 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.034115e-05 | 4.298 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.886211e-05 | 4.230 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.773466e-05 | 4.239 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.272801e-05 | 4.203 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.327631e-05 | 4.199 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 7.035920e-05 | 4.153 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.167543e-05 | 4.145 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.167543e-05 | 4.145 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.841898e-05 | 4.053 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.569768e-05 | 4.067 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 9.216023e-05 | 4.035 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.989729e-05 | 4.046 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.807014e-05 | 4.008 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.807014e-05 | 4.008 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.089881e-04 | 3.963 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.340715e-04 | 3.873 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.288219e-04 | 3.890 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.288219e-04 | 3.890 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.419404e-04 | 3.848 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.913284e-04 | 3.718 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.985592e-04 | 3.702 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.232583e-04 | 3.651 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.236679e-04 | 3.650 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.380540e-04 | 3.623 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.395026e-04 | 3.621 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.303703e-04 | 3.638 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.574299e-04 | 3.589 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.574858e-04 | 3.589 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.744138e-04 | 3.562 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.868483e-04 | 3.542 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.040359e-04 | 3.517 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.103977e-04 | 3.508 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.123663e-04 | 3.505 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.526411e-04 | 3.453 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.526411e-04 | 3.453 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.615211e-04 | 3.442 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.842188e-04 | 3.415 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.716512e-04 | 3.430 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.804092e-04 | 3.420 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.929369e-04 | 3.307 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.748282e-04 | 3.323 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.173962e-04 | 3.286 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.338194e-04 | 3.363 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.366415e-04 | 3.360 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.391565e-04 | 3.357 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.391565e-04 | 3.357 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.391565e-04 | 3.357 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.391565e-04 | 3.357 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.931871e-04 | 3.307 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.399030e-04 | 3.357 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.173962e-04 | 3.286 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.391565e-04 | 3.357 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.449658e-04 | 3.264 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.646080e-04 | 3.248 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.841624e-04 | 3.233 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.832037e-04 | 3.234 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.290206e-04 | 3.201 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.763627e-04 | 3.170 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.763627e-04 | 3.170 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.839659e-04 | 3.165 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.378417e-04 | 3.195 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.839659e-04 | 3.165 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.375154e-04 | 3.196 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.375154e-04 | 3.196 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.941187e-04 | 3.159 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.228938e-04 | 3.141 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.802443e-04 | 3.108 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.928851e-04 | 3.101 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.027836e-04 | 3.095 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.081707e-04 | 3.092 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.171421e-04 | 3.088 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 8.892813e-04 | 3.051 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.969054e-04 | 3.047 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 9.237774e-04 | 3.034 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.237774e-04 | 3.034 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.237774e-04 | 3.034 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.767306e-04 | 3.010 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.022840e-03 | 2.990 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.071618e-03 | 2.970 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.097226e-03 | 2.960 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.097226e-03 | 2.960 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.097226e-03 | 2.960 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.039131e-03 | 2.983 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.039131e-03 | 2.983 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.112653e-03 | 2.954 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.139051e-03 | 2.943 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.270281e-03 | 2.896 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.335483e-03 | 2.874 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.441598e-03 | 2.841 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.486151e-03 | 2.828 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.378250e-03 | 2.861 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.417886e-03 | 2.848 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.503283e-03 | 2.823 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.396260e-03 | 2.855 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.409395e-03 | 2.851 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.582346e-03 | 2.801 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.675440e-03 | 2.776 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.676064e-03 | 2.776 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.731725e-03 | 2.762 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.780293e-03 | 2.750 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.780293e-03 | 2.750 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.986448e-03 | 2.702 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.909762e-03 | 2.719 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.986448e-03 | 2.702 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.915814e-03 | 2.718 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.986448e-03 | 2.702 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.986448e-03 | 2.702 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.925130e-03 | 2.716 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.986448e-03 | 2.702 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.069762e-03 | 2.684 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.070571e-03 | 2.684 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.070571e-03 | 2.684 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.070571e-03 | 2.684 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.216832e-03 | 2.654 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.293389e-03 | 2.640 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.293389e-03 | 2.640 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.401805e-03 | 2.619 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.330386e-03 | 2.633 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.200963e-03 | 2.657 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.442558e-03 | 2.612 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.554761e-03 | 2.593 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.566515e-03 | 2.591 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.574203e-03 | 2.589 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.574203e-03 | 2.589 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.608533e-03 | 2.584 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.668991e-03 | 2.574 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.707466e-03 | 2.567 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.707466e-03 | 2.567 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.707466e-03 | 2.567 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.762044e-03 | 2.559 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.762044e-03 | 2.559 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.779728e-03 | 2.556 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.825191e-03 | 2.549 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.825191e-03 | 2.549 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.052308e-03 | 2.515 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.092636e-03 | 2.510 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.270478e-03 | 2.485 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.886931e-03 | 2.540 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.270478e-03 | 2.485 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.169280e-03 | 2.499 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.270478e-03 | 2.485 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.270478e-03 | 2.485 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.960224e-03 | 2.529 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.270478e-03 | 2.485 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.275245e-03 | 2.485 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.275245e-03 | 2.485 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 3.278760e-03 | 2.484 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.378280e-03 | 2.471 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.399626e-03 | 2.469 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.399626e-03 | 2.469 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.523298e-03 | 2.453 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.523298e-03 | 2.453 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.590236e-03 | 2.445 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.702834e-03 | 2.431 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.742214e-03 | 2.427 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.883301e-03 | 2.411 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.112373e-03 | 2.386 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.927263e-03 | 2.406 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.516969e-03 | 2.345 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.549463e-03 | 2.342 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.440322e-03 | 2.353 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.509037e-03 | 2.346 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.509037e-03 | 2.346 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.448968e-03 | 2.352 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.112373e-03 | 2.386 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.016069e-03 | 2.396 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.519797e-03 | 2.345 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.122530e-03 | 2.385 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.549463e-03 | 2.342 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.288552e-03 | 2.368 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.577824e-03 | 2.339 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.577824e-03 | 2.339 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.633077e-03 | 2.334 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.670707e-03 | 2.331 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.670707e-03 | 2.331 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.675089e-03 | 2.330 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.863813e-03 | 2.313 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.880813e-03 | 2.312 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.087221e-03 | 2.294 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.274926e-03 | 2.278 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.480765e-03 | 2.261 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.621998e-03 | 2.250 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.863388e-03 | 2.232 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.863388e-03 | 2.232 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.982024e-03 | 2.223 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.003546e-03 | 2.222 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.003546e-03 | 2.222 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.003546e-03 | 2.222 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.148971e-03 | 2.211 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.215302e-03 | 2.207 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.215302e-03 | 2.207 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.218822e-03 | 2.206 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.399171e-03 | 2.194 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.460809e-03 | 2.190 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.854177e-03 | 2.164 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.422519e-03 | 2.129 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.518631e-03 | 2.186 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.779114e-03 | 2.109 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.779114e-03 | 2.109 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.603670e-03 | 2.119 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.779114e-03 | 2.109 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.521905e-03 | 2.124 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.561539e-03 | 2.121 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.640115e-03 | 2.117 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.779114e-03 | 2.109 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.975996e-03 | 2.098 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.200723e-03 | 2.086 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.357118e-03 | 2.078 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.388482e-03 | 2.076 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.703221e-03 | 2.060 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.877876e-03 | 2.052 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.977661e-03 | 2.047 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.977661e-03 | 2.047 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.977661e-03 | 2.047 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.496005e-03 | 2.022 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 9.554838e-03 | 2.020 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.914968e-03 | 2.004 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.007864e-02 | 1.997 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.012580e-02 | 1.995 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.027966e-02 | 1.988 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.027966e-02 | 1.988 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.063418e-02 | 1.973 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.063418e-02 | 1.973 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.070767e-02 | 1.970 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.186492e-02 | 1.926 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.345762e-02 | 1.871 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.186141e-02 | 1.926 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.303776e-02 | 1.885 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.303776e-02 | 1.885 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.137038e-02 | 1.944 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.212093e-02 | 1.916 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.212093e-02 | 1.916 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.145439e-02 | 1.941 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.321666e-02 | 1.879 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.113003e-02 | 1.954 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.137038e-02 | 1.944 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.254413e-02 | 1.902 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.082348e-02 | 1.966 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.186141e-02 | 1.926 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.186141e-02 | 1.926 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.254413e-02 | 1.902 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.186141e-02 | 1.926 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.339062e-02 | 1.873 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.186141e-02 | 1.926 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.141624e-02 | 1.942 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.380435e-02 | 1.860 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.387799e-02 | 1.858 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.439532e-02 | 1.842 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.454964e-02 | 1.837 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.475554e-02 | 1.831 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.476832e-02 | 1.831 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.476832e-02 | 1.831 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.476832e-02 | 1.831 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.476832e-02 | 1.831 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.482647e-02 | 1.829 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.542004e-02 | 1.812 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.542004e-02 | 1.812 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.542004e-02 | 1.812 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.564388e-02 | 1.806 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.587772e-02 | 1.799 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.612238e-02 | 1.793 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.639918e-02 | 1.785 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.659780e-02 | 1.780 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.659780e-02 | 1.780 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.665225e-02 | 1.779 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.665225e-02 | 1.779 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.665225e-02 | 1.779 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.665225e-02 | 1.779 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.667653e-02 | 1.778 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.673925e-02 | 1.776 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.682748e-02 | 1.774 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.708006e-02 | 1.768 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.710724e-02 | 1.767 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.718796e-02 | 1.765 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.747660e-02 | 1.758 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.747660e-02 | 1.758 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.755169e-02 | 1.756 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.774623e-02 | 1.751 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.782125e-02 | 1.749 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.813765e-02 | 1.741 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.869547e-02 | 1.728 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.886232e-02 | 1.724 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.886232e-02 | 1.724 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.886232e-02 | 1.724 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.933019e-02 | 1.714 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 2.035775e-02 | 1.691 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.081109e-02 | 1.682 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 2.081109e-02 | 1.682 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.451054e-02 | 1.611 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 2.451054e-02 | 1.611 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.504017e-02 | 1.601 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.090355e-02 | 1.680 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.090355e-02 | 1.680 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.328178e-02 | 1.633 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.977721e-02 | 1.704 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.532483e-02 | 1.596 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.986614e-02 | 1.702 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.583505e-02 | 1.588 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.090355e-02 | 1.680 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.081109e-02 | 1.682 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.265903e-02 | 1.645 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.081109e-02 | 1.682 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.583505e-02 | 1.588 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.943351e-02 | 1.711 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.090355e-02 | 1.680 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.042045e-02 | 1.690 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.498293e-02 | 1.602 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.583505e-02 | 1.588 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.151960e-02 | 1.667 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.328178e-02 | 1.633 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.328178e-02 | 1.633 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.583505e-02 | 1.588 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.532483e-02 | 1.596 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.544901e-02 | 1.594 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.081109e-02 | 1.682 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.225338e-02 | 1.653 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.995204e-02 | 1.700 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.010147e-02 | 1.697 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.498293e-02 | 1.602 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.977721e-02 | 1.704 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.280989e-02 | 1.642 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.059164e-02 | 1.686 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.357380e-02 | 1.628 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.707930e-02 | 1.567 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.727811e-02 | 1.564 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.729363e-02 | 1.564 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 2.826047e-02 | 1.549 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 2.826047e-02 | 1.549 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 2.826047e-02 | 1.549 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.833239e-02 | 1.548 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.833239e-02 | 1.548 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.834877e-02 | 1.547 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.834877e-02 | 1.547 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.834877e-02 | 1.547 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.834877e-02 | 1.547 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.856789e-02 | 1.544 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.856789e-02 | 1.544 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.856789e-02 | 1.544 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.856789e-02 | 1.544 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.856789e-02 | 1.544 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.856789e-02 | 1.544 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.858263e-02 | 1.544 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.858263e-02 | 1.544 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.863984e-02 | 1.543 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.957619e-02 | 1.529 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.974537e-02 | 1.527 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.067587e-02 | 1.513 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.070498e-02 | 1.513 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.113429e-02 | 1.507 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.148445e-02 | 1.502 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.173166e-02 | 1.499 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.173166e-02 | 1.499 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.253586e-02 | 1.488 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 3.303297e-02 | 1.481 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.303297e-02 | 1.481 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 3.303297e-02 | 1.481 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.402938e-02 | 1.468 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.458846e-02 | 1.461 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.458846e-02 | 1.461 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.458846e-02 | 1.461 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.458846e-02 | 1.461 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.466096e-02 | 1.460 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.504599e-02 | 1.455 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.545821e-02 | 1.450 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.545821e-02 | 1.450 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.545821e-02 | 1.450 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.738390e-02 | 1.427 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.786520e-02 | 1.422 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.788324e-02 | 1.422 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.788324e-02 | 1.422 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 5.277174e-02 | 1.278 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 5.277174e-02 | 1.278 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.610491e-02 | 1.251 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.163580e-02 | 1.381 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.925857e-02 | 1.308 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.925857e-02 | 1.308 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.751039e-02 | 1.240 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.308108e-02 | 1.366 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.868052e-02 | 1.313 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.868052e-02 | 1.313 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.868052e-02 | 1.313 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.868052e-02 | 1.313 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.868052e-02 | 1.313 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.369119e-02 | 1.360 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.369119e-02 | 1.360 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.820244e-02 | 1.317 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.757780e-02 | 1.323 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.142615e-02 | 1.289 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.365445e-02 | 1.270 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.308108e-02 | 1.366 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.466173e-02 | 1.262 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.268771e-02 | 1.370 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.507025e-02 | 1.346 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.925857e-02 | 1.308 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 5.466173e-02 | 1.262 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.505625e-02 | 1.346 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.925857e-02 | 1.308 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.925857e-02 | 1.308 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.893897e-02 | 1.310 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.109176e-02 | 1.292 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.530214e-02 | 1.344 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.889177e-02 | 1.311 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.610491e-02 | 1.251 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.302144e-02 | 1.276 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.308108e-02 | 1.366 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 4.308108e-02 | 1.366 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.057468e-02 | 1.392 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.820244e-02 | 1.317 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.461484e-02 | 1.351 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.301213e-02 | 1.276 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.302144e-02 | 1.276 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.949857e-02 | 1.403 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.744112e-02 | 1.324 | 0 | 0 |
| Translation | R-HSA-72766 | 5.304891e-02 | 1.275 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.297871e-02 | 1.276 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.893897e-02 | 1.310 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.802040e-02 | 1.236 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.137168e-02 | 1.383 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.495555e-02 | 1.260 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.540842e-02 | 1.343 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.228789e-02 | 1.374 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 5.610491e-02 | 1.251 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.466173e-02 | 1.262 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.893897e-02 | 1.310 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.893897e-02 | 1.310 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.365445e-02 | 1.270 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.243410e-02 | 1.280 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.475444e-02 | 1.262 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.466173e-02 | 1.262 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.733032e-02 | 1.242 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.893897e-02 | 1.310 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.610491e-02 | 1.251 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.757780e-02 | 1.323 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 5.466173e-02 | 1.262 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.944378e-02 | 1.404 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.369119e-02 | 1.360 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.802040e-02 | 1.236 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.893897e-02 | 1.310 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 4.868052e-02 | 1.313 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.302144e-02 | 1.276 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.859916e-02 | 1.232 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.996443e-02 | 1.222 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.102131e-02 | 1.215 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.102131e-02 | 1.215 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.102131e-02 | 1.215 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.178972e-02 | 1.209 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.327204e-02 | 1.199 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.327204e-02 | 1.199 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.332712e-02 | 1.198 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.332712e-02 | 1.198 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.332712e-02 | 1.198 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.459970e-02 | 1.190 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.545730e-02 | 1.184 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.545730e-02 | 1.184 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.636900e-02 | 1.178 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.636900e-02 | 1.178 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.636900e-02 | 1.178 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.636900e-02 | 1.178 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.642215e-02 | 1.178 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.647653e-02 | 1.177 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.775432e-02 | 1.169 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.775432e-02 | 1.169 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.872123e-02 | 1.163 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.889773e-02 | 1.162 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.930104e-02 | 1.159 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.930685e-02 | 1.159 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.028709e-02 | 1.153 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.028709e-02 | 1.153 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 7.077217e-02 | 1.150 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 7.077217e-02 | 1.150 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 7.077217e-02 | 1.150 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.106163e-02 | 1.148 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.136504e-02 | 1.147 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.136504e-02 | 1.147 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.136504e-02 | 1.147 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.136504e-02 | 1.147 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.136504e-02 | 1.147 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.395903e-02 | 1.131 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.419368e-02 | 1.130 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.473036e-02 | 1.127 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.473036e-02 | 1.127 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.473036e-02 | 1.127 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.485444e-02 | 1.126 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.555417e-02 | 1.122 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.645470e-02 | 1.117 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.645470e-02 | 1.117 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.739500e-02 | 1.111 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.743791e-02 | 1.111 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 8.019863e-02 | 1.096 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.100724e-02 | 1.091 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.227596e-02 | 1.085 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.231405e-02 | 1.085 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.231405e-02 | 1.085 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.500481e-02 | 1.071 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.500481e-02 | 1.071 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.580374e-02 | 1.066 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.580374e-02 | 1.066 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.580374e-02 | 1.066 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 8.652052e-02 | 1.063 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.652052e-02 | 1.063 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 8.652052e-02 | 1.063 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.980904e-02 | 1.047 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.012435e-02 | 1.045 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 9.012435e-02 | 1.045 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.055231e-02 | 1.043 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.075351e-02 | 1.042 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.291855e-02 | 1.032 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.509912e-02 | 1.022 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.509912e-02 | 1.022 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.509912e-02 | 1.022 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.509912e-02 | 1.022 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.520790e-02 | 1.021 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 9.632325e-02 | 1.016 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 9.632325e-02 | 1.016 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 9.632325e-02 | 1.016 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.662355e-02 | 1.015 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.780251e-02 | 1.010 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.027617e-01 | 0.988 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.027617e-01 | 0.988 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.027617e-01 | 0.988 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.027617e-01 | 0.988 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.027617e-01 | 0.988 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.501162e-01 | 0.824 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.501162e-01 | 0.824 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.501162e-01 | 0.824 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.501162e-01 | 0.824 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 1.501162e-01 | 0.824 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.501162e-01 | 0.824 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 1.501162e-01 | 0.824 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.949742e-01 | 0.710 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.949742e-01 | 0.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.949742e-01 | 0.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.949742e-01 | 0.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.949742e-01 | 0.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.949742e-01 | 0.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.949742e-01 | 0.710 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.949742e-01 | 0.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.949742e-01 | 0.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.949742e-01 | 0.710 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.949742e-01 | 0.710 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.949742e-01 | 0.710 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.031953e-01 | 0.986 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.206551e-01 | 0.918 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.206551e-01 | 0.918 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.206551e-01 | 0.918 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.387710e-01 | 0.858 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.574251e-01 | 0.803 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.574251e-01 | 0.803 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.073372e-01 | 0.969 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.765105e-01 | 0.753 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.765105e-01 | 0.753 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.765105e-01 | 0.753 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.959299e-01 | 0.708 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 1.959299e-01 | 0.708 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.959299e-01 | 0.708 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.959299e-01 | 0.708 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.307211e-01 | 0.884 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.686992e-01 | 0.773 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.340588e-01 | 0.873 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.820021e-01 | 0.740 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.820021e-01 | 0.740 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.820021e-01 | 0.740 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.077110e-01 | 0.968 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.111333e-01 | 0.954 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.383846e-01 | 0.859 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.724145e-01 | 0.763 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.724145e-01 | 0.763 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.724145e-01 | 0.763 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.724145e-01 | 0.763 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.524789e-01 | 0.817 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.353335e-01 | 0.869 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.547783e-01 | 0.810 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.684162e-01 | 0.774 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.684162e-01 | 0.774 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.611467e-01 | 0.793 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.549788e-01 | 0.810 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.052006e-01 | 0.978 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.738182e-01 | 0.760 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.481583e-01 | 0.829 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.303830e-01 | 0.885 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.536771e-01 | 0.813 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.574251e-01 | 0.803 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.955733e-01 | 0.709 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.724145e-01 | 0.763 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.031953e-01 | 0.986 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 1.206551e-01 | 0.918 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.048714e-01 | 0.979 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.574251e-01 | 0.803 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.611467e-01 | 0.793 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 1.959299e-01 | 0.708 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.827546e-02 | 1.008 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.246610e-01 | 0.904 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.087343e-01 | 0.964 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.936230e-01 | 0.713 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.849435e-01 | 0.733 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.614812e-01 | 0.792 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.742960e-01 | 0.759 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.765105e-01 | 0.753 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.307211e-01 | 0.884 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.111333e-01 | 0.954 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.067565e-01 | 0.972 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.638689e-01 | 0.786 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.559536e-01 | 0.807 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.150394e-01 | 0.939 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.150394e-01 | 0.939 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.387710e-01 | 0.858 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.318023e-01 | 0.880 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.073372e-01 | 0.969 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.318023e-01 | 0.880 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.314843e-01 | 0.881 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.393746e-01 | 0.856 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.087710e-01 | 0.963 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.481583e-01 | 0.829 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.027617e-01 | 0.988 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 1.501162e-01 | 0.824 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.501162e-01 | 0.824 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.501162e-01 | 0.824 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 1.949742e-01 | 0.710 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 1.949742e-01 | 0.710 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.387710e-01 | 0.858 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.765105e-01 | 0.753 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.959299e-01 | 0.708 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.959299e-01 | 0.708 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.820021e-01 | 0.740 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.753799e-01 | 0.756 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.450177e-01 | 0.839 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.428255e-01 | 0.845 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.428255e-01 | 0.845 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.428255e-01 | 0.845 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.152908e-01 | 0.938 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.175814e-01 | 0.930 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.833099e-01 | 0.737 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.957959e-01 | 0.708 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 1.188139e-01 | 0.925 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.820021e-01 | 0.740 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.099742e-01 | 0.959 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.225990e-01 | 0.912 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.248592e-01 | 0.904 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.879885e-02 | 1.005 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.481583e-01 | 0.829 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.188139e-01 | 0.925 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.188139e-01 | 0.925 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 1.340588e-01 | 0.873 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 1.383846e-01 | 0.859 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.913788e-01 | 0.718 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.272768e-01 | 0.895 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.501162e-01 | 0.824 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 1.949742e-01 | 0.710 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.949742e-01 | 0.710 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.949742e-01 | 0.710 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 1.206551e-01 | 0.918 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 1.206551e-01 | 0.918 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.387710e-01 | 0.858 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.574251e-01 | 0.803 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.073372e-01 | 0.969 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.959299e-01 | 0.708 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.686992e-01 | 0.773 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 1.383846e-01 | 0.859 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.002533e-01 | 0.999 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.575918e-01 | 0.802 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.006198e-01 | 0.997 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.436092e-01 | 0.843 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.724145e-01 | 0.763 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.957959e-01 | 0.708 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.738182e-01 | 0.760 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 1.753799e-01 | 0.756 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.550108e-01 | 0.810 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.832672e-01 | 0.737 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.686992e-01 | 0.773 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.031953e-01 | 0.986 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.067565e-01 | 0.972 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.820021e-01 | 0.740 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.416757e-01 | 0.849 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.067565e-01 | 0.972 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.905284e-01 | 0.720 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.067565e-01 | 0.972 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.820021e-01 | 0.740 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.387710e-01 | 0.858 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.686992e-01 | 0.773 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.003850e-01 | 0.998 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.724145e-01 | 0.763 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.380053e-01 | 0.860 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.636196e-01 | 0.786 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.898133e-01 | 0.722 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.383846e-01 | 0.859 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.742960e-01 | 0.759 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.849435e-01 | 0.733 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.833099e-01 | 0.737 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.803163e-01 | 0.744 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.048714e-01 | 0.979 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.387710e-01 | 0.858 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 1.246610e-01 | 0.904 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.898133e-01 | 0.722 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 1.936230e-01 | 0.713 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.077110e-01 | 0.968 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.998296e-01 | 0.699 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.020098e-01 | 0.695 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.046584e-01 | 0.689 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.084286e-01 | 0.681 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.093816e-01 | 0.679 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.093816e-01 | 0.679 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.122425e-01 | 0.673 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.143128e-01 | 0.669 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.149289e-01 | 0.668 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.155949e-01 | 0.666 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.155949e-01 | 0.666 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.155949e-01 | 0.666 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.155949e-01 | 0.666 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.155949e-01 | 0.666 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.155949e-01 | 0.666 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 2.155949e-01 | 0.666 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.155949e-01 | 0.666 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.155949e-01 | 0.666 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.155949e-01 | 0.666 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.155949e-01 | 0.666 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.155949e-01 | 0.666 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.155949e-01 | 0.666 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.163590e-01 | 0.665 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 2.163590e-01 | 0.665 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.188753e-01 | 0.660 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.230469e-01 | 0.652 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.233965e-01 | 0.651 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 2.233965e-01 | 0.651 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.233965e-01 | 0.651 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.233965e-01 | 0.651 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.233965e-01 | 0.651 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.285545e-01 | 0.641 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.294299e-01 | 0.639 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.335960e-01 | 0.632 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.354257e-01 | 0.628 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.354257e-01 | 0.628 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.354257e-01 | 0.628 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.368680e-01 | 0.625 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.374671e-01 | 0.624 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.374671e-01 | 0.624 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 2.374671e-01 | 0.624 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 2.374671e-01 | 0.624 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 2.374671e-01 | 0.624 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 2.374671e-01 | 0.624 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 2.374671e-01 | 0.624 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 2.374671e-01 | 0.624 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.374671e-01 | 0.624 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.375884e-01 | 0.624 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.375884e-01 | 0.624 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.384501e-01 | 0.623 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.388352e-01 | 0.622 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.409490e-01 | 0.618 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.416913e-01 | 0.617 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.515996e-01 | 0.599 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.519286e-01 | 0.599 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.525967e-01 | 0.598 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.525967e-01 | 0.598 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.553501e-01 | 0.593 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 2.553501e-01 | 0.593 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.553501e-01 | 0.593 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.624848e-01 | 0.581 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.643580e-01 | 0.578 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.655264e-01 | 0.576 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 2.663893e-01 | 0.574 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.686410e-01 | 0.571 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.686410e-01 | 0.571 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.695381e-01 | 0.569 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.695381e-01 | 0.569 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.753031e-01 | 0.560 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.753031e-01 | 0.560 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.753031e-01 | 0.560 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.753031e-01 | 0.560 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.753031e-01 | 0.560 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.753031e-01 | 0.560 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.753031e-01 | 0.560 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.753031e-01 | 0.560 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.777194e-01 | 0.556 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.777194e-01 | 0.556 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.777194e-01 | 0.556 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.777194e-01 | 0.556 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.777194e-01 | 0.556 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.777194e-01 | 0.556 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.777194e-01 | 0.556 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.777194e-01 | 0.556 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.777194e-01 | 0.556 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 2.777194e-01 | 0.556 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 2.783610e-01 | 0.555 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.815210e-01 | 0.550 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.838101e-01 | 0.547 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.881631e-01 | 0.540 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.881631e-01 | 0.540 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.892115e-01 | 0.539 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.933281e-01 | 0.533 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.933281e-01 | 0.533 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.952263e-01 | 0.530 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.952263e-01 | 0.530 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.952263e-01 | 0.530 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.955671e-01 | 0.529 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.955671e-01 | 0.529 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.955671e-01 | 0.529 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.955671e-01 | 0.529 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.968003e-01 | 0.528 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 2.968003e-01 | 0.528 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.982826e-01 | 0.525 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.982826e-01 | 0.525 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.982826e-01 | 0.525 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 2.996021e-01 | 0.523 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.013714e-01 | 0.521 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.042955e-01 | 0.517 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.061084e-01 | 0.514 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 3.100508e-01 | 0.509 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.102342e-01 | 0.508 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.102342e-01 | 0.508 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.102342e-01 | 0.508 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.122498e-01 | 0.505 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.150673e-01 | 0.502 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.150673e-01 | 0.502 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.150673e-01 | 0.502 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.150673e-01 | 0.502 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.150673e-01 | 0.502 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.150673e-01 | 0.502 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.150673e-01 | 0.502 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.158493e-01 | 0.501 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.158493e-01 | 0.501 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 3.158493e-01 | 0.501 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.158493e-01 | 0.501 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.158493e-01 | 0.501 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 3.158493e-01 | 0.501 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.158493e-01 | 0.501 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 3.158493e-01 | 0.501 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.158493e-01 | 0.501 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 3.158493e-01 | 0.501 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.203141e-01 | 0.494 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.203141e-01 | 0.494 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.236301e-01 | 0.490 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.243644e-01 | 0.489 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.248696e-01 | 0.488 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.249221e-01 | 0.488 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.249221e-01 | 0.488 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.249221e-01 | 0.488 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 3.310398e-01 | 0.480 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 3.310868e-01 | 0.480 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.310868e-01 | 0.480 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.347792e-01 | 0.475 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.347792e-01 | 0.475 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.347792e-01 | 0.475 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.396087e-01 | 0.469 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.396087e-01 | 0.469 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.437698e-01 | 0.464 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.501634e-01 | 0.456 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.512426e-01 | 0.454 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.519684e-01 | 0.453 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 3.519684e-01 | 0.453 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 3.519684e-01 | 0.453 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.519684e-01 | 0.453 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.519684e-01 | 0.453 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.519684e-01 | 0.453 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.519684e-01 | 0.453 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.519684e-01 | 0.453 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 3.519684e-01 | 0.453 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.519684e-01 | 0.453 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.519684e-01 | 0.453 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.519684e-01 | 0.453 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.519684e-01 | 0.453 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.542730e-01 | 0.451 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.542730e-01 | 0.451 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.542730e-01 | 0.451 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.542730e-01 | 0.451 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.542730e-01 | 0.451 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.542730e-01 | 0.451 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.543206e-01 | 0.451 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.543206e-01 | 0.451 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.543206e-01 | 0.451 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.608370e-01 | 0.443 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.608370e-01 | 0.443 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.616370e-01 | 0.442 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.616370e-01 | 0.442 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.616370e-01 | 0.442 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.688952e-01 | 0.433 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.688952e-01 | 0.433 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 3.723264e-01 | 0.429 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.727992e-01 | 0.429 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.736546e-01 | 0.428 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.736546e-01 | 0.428 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.736546e-01 | 0.428 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.736546e-01 | 0.428 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.736546e-01 | 0.428 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.736546e-01 | 0.428 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 3.778496e-01 | 0.423 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.861827e-01 | 0.413 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 3.861827e-01 | 0.413 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.861827e-01 | 0.413 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 3.861827e-01 | 0.413 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.861827e-01 | 0.413 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.861827e-01 | 0.413 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 3.861827e-01 | 0.413 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.914040e-01 | 0.407 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.922097e-01 | 0.406 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.927485e-01 | 0.406 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.927485e-01 | 0.406 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.927485e-01 | 0.406 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.946925e-01 | 0.404 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.965492e-01 | 0.402 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.965492e-01 | 0.402 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.979403e-01 | 0.400 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.115740e-01 | 0.386 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.115740e-01 | 0.386 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.118752e-01 | 0.385 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.123293e-01 | 0.385 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.123293e-01 | 0.385 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.123293e-01 | 0.385 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.123293e-01 | 0.385 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.123293e-01 | 0.385 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.185925e-01 | 0.378 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.185925e-01 | 0.378 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.185925e-01 | 0.378 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 4.185925e-01 | 0.378 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.185925e-01 | 0.378 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.185925e-01 | 0.378 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.185925e-01 | 0.378 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 4.185925e-01 | 0.378 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.185925e-01 | 0.378 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.185925e-01 | 0.378 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.185925e-01 | 0.378 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 4.185925e-01 | 0.378 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.185925e-01 | 0.378 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.185925e-01 | 0.378 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.199793e-01 | 0.377 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.266086e-01 | 0.370 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.268744e-01 | 0.370 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.280773e-01 | 0.368 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 4.301062e-01 | 0.366 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.301062e-01 | 0.366 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.315902e-01 | 0.365 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 4.342034e-01 | 0.362 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.368809e-01 | 0.360 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.407640e-01 | 0.356 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.451952e-01 | 0.351 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.483236e-01 | 0.348 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.487058e-01 | 0.348 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.487560e-01 | 0.348 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.492930e-01 | 0.347 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.492930e-01 | 0.347 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.492930e-01 | 0.347 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.547823e-01 | 0.342 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.551082e-01 | 0.342 | 1 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.562627e-01 | 0.341 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.574574e-01 | 0.340 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.577399e-01 | 0.339 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.603936e-01 | 0.337 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 4.662077e-01 | 0.331 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.662077e-01 | 0.331 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.662077e-01 | 0.331 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.668719e-01 | 0.331 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.686514e-01 | 0.329 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.686514e-01 | 0.329 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.686514e-01 | 0.329 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.686514e-01 | 0.329 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.746588e-01 | 0.324 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.783741e-01 | 0.320 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.783741e-01 | 0.320 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.783741e-01 | 0.320 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.783741e-01 | 0.320 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.783741e-01 | 0.320 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.783741e-01 | 0.320 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.783741e-01 | 0.320 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.783741e-01 | 0.320 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.783741e-01 | 0.320 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.786037e-01 | 0.320 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.823602e-01 | 0.317 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.837431e-01 | 0.315 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.837431e-01 | 0.315 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 4.837431e-01 | 0.315 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.837431e-01 | 0.315 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.839587e-01 | 0.315 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.885945e-01 | 0.311 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.888621e-01 | 0.311 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.888621e-01 | 0.311 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.888621e-01 | 0.311 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.958984e-01 | 0.305 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.958984e-01 | 0.305 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.958984e-01 | 0.305 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.958984e-01 | 0.305 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 4.958984e-01 | 0.305 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.958984e-01 | 0.305 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 4.987413e-01 | 0.302 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.990571e-01 | 0.302 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 5.009167e-01 | 0.300 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.009167e-01 | 0.300 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 5.009167e-01 | 0.300 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.009167e-01 | 0.300 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 5.033332e-01 | 0.298 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.033332e-01 | 0.298 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.046434e-01 | 0.297 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.059211e-01 | 0.296 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.059211e-01 | 0.296 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.059211e-01 | 0.296 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.059211e-01 | 0.296 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.059211e-01 | 0.296 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.059211e-01 | 0.296 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 5.059211e-01 | 0.296 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.059211e-01 | 0.296 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.088105e-01 | 0.293 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.092406e-01 | 0.293 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 5.092568e-01 | 0.293 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.092568e-01 | 0.293 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.146444e-01 | 0.288 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.146444e-01 | 0.288 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.169777e-01 | 0.287 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.177177e-01 | 0.286 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.177177e-01 | 0.286 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 5.177177e-01 | 0.286 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.222673e-01 | 0.282 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.224270e-01 | 0.282 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.286972e-01 | 0.277 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.320150e-01 | 0.274 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 5.320150e-01 | 0.274 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.320150e-01 | 0.274 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 5.320150e-01 | 0.274 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 5.320150e-01 | 0.274 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.320150e-01 | 0.274 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.320150e-01 | 0.274 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.320150e-01 | 0.274 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.320150e-01 | 0.274 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.320150e-01 | 0.274 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.320150e-01 | 0.274 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.320150e-01 | 0.274 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.341378e-01 | 0.272 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.341378e-01 | 0.272 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.341378e-01 | 0.272 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.341378e-01 | 0.272 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.341378e-01 | 0.272 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.357248e-01 | 0.271 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.401428e-01 | 0.267 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.478326e-01 | 0.261 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.478326e-01 | 0.261 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.481731e-01 | 0.261 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.481731e-01 | 0.261 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.482192e-01 | 0.261 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.489713e-01 | 0.260 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.501702e-01 | 0.260 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.501702e-01 | 0.260 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.501702e-01 | 0.260 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 5.501702e-01 | 0.260 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.501702e-01 | 0.260 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.509863e-01 | 0.259 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.567323e-01 | 0.254 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.567323e-01 | 0.254 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.567323e-01 | 0.254 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.567323e-01 | 0.254 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.585395e-01 | 0.253 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.586294e-01 | 0.253 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.586294e-01 | 0.253 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.658101e-01 | 0.247 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.660301e-01 | 0.247 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.673451e-01 | 0.246 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 5.730856e-01 | 0.242 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.749836e-01 | 0.240 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.797971e-01 | 0.237 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.801456e-01 | 0.236 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.801456e-01 | 0.236 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.801456e-01 | 0.236 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.801456e-01 | 0.236 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.801456e-01 | 0.236 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 5.801456e-01 | 0.236 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.801456e-01 | 0.236 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.801456e-01 | 0.236 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.801456e-01 | 0.236 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.801456e-01 | 0.236 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.801456e-01 | 0.236 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.810543e-01 | 0.236 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.810543e-01 | 0.236 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.901602e-01 | 0.229 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.901602e-01 | 0.229 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.952320e-01 | 0.225 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 5.974219e-01 | 0.224 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.023235e-01 | 0.220 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.023235e-01 | 0.220 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.023235e-01 | 0.220 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.023235e-01 | 0.220 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 6.023235e-01 | 0.220 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 6.023235e-01 | 0.220 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.023235e-01 | 0.220 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.023235e-01 | 0.220 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.026489e-01 | 0.220 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.027203e-01 | 0.220 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.043020e-01 | 0.219 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.103493e-01 | 0.214 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.104283e-01 | 0.214 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.104283e-01 | 0.214 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.233311e-01 | 0.205 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.233311e-01 | 0.205 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.233311e-01 | 0.205 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.233311e-01 | 0.205 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.233311e-01 | 0.205 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.233311e-01 | 0.205 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.233311e-01 | 0.205 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 6.233311e-01 | 0.205 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.233311e-01 | 0.205 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.233311e-01 | 0.205 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.244003e-01 | 0.205 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.244003e-01 | 0.205 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.244003e-01 | 0.205 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.284328e-01 | 0.202 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.314868e-01 | 0.200 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.314868e-01 | 0.200 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.314868e-01 | 0.200 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.325936e-01 | 0.199 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.380554e-01 | 0.195 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.380554e-01 | 0.195 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.424789e-01 | 0.192 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.424789e-01 | 0.192 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.424789e-01 | 0.192 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.432303e-01 | 0.192 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.432303e-01 | 0.192 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.432303e-01 | 0.192 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.432303e-01 | 0.192 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 6.432303e-01 | 0.192 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.432303e-01 | 0.192 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 6.432303e-01 | 0.192 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.432303e-01 | 0.192 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.432303e-01 | 0.192 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.432303e-01 | 0.192 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.432303e-01 | 0.192 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.478543e-01 | 0.189 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.511397e-01 | 0.186 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.513173e-01 | 0.186 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.583108e-01 | 0.182 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.620793e-01 | 0.179 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.620793e-01 | 0.179 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.620793e-01 | 0.179 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 6.620793e-01 | 0.179 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.620793e-01 | 0.179 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 6.620793e-01 | 0.179 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.620793e-01 | 0.179 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.620793e-01 | 0.179 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 6.620793e-01 | 0.179 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.673950e-01 | 0.176 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.708375e-01 | 0.173 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.718054e-01 | 0.173 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.761629e-01 | 0.170 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.766758e-01 | 0.170 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.766758e-01 | 0.170 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.799335e-01 | 0.168 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.799335e-01 | 0.168 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.799335e-01 | 0.168 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.799335e-01 | 0.168 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.799335e-01 | 0.168 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.835886e-01 | 0.165 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.853634e-01 | 0.164 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.887815e-01 | 0.162 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.887815e-01 | 0.162 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.902425e-01 | 0.161 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.968454e-01 | 0.157 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.968454e-01 | 0.157 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.968454e-01 | 0.157 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.968454e-01 | 0.157 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.005116e-01 | 0.155 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.005116e-01 | 0.155 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.014315e-01 | 0.154 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.014315e-01 | 0.154 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.035098e-01 | 0.153 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.063948e-01 | 0.151 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.118722e-01 | 0.148 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.118722e-01 | 0.148 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.118722e-01 | 0.148 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.120452e-01 | 0.147 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.128647e-01 | 0.147 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.128647e-01 | 0.147 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 7.128647e-01 | 0.147 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 7.128647e-01 | 0.147 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.128647e-01 | 0.147 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 7.128647e-01 | 0.147 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.128647e-01 | 0.147 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.128647e-01 | 0.147 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.128647e-01 | 0.147 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.128647e-01 | 0.147 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.128858e-01 | 0.147 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.128858e-01 | 0.147 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.128858e-01 | 0.147 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.169628e-01 | 0.145 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.199563e-01 | 0.143 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.220162e-01 | 0.141 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.225147e-01 | 0.141 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.225990e-01 | 0.141 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.228694e-01 | 0.141 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.228694e-01 | 0.141 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.228694e-01 | 0.141 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.228694e-01 | 0.141 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.228694e-01 | 0.141 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.280384e-01 | 0.138 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.280384e-01 | 0.138 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.280384e-01 | 0.138 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.280384e-01 | 0.138 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.280384e-01 | 0.138 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.280384e-01 | 0.138 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.280384e-01 | 0.138 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.309188e-01 | 0.136 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.314383e-01 | 0.136 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.314383e-01 | 0.136 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.335100e-01 | 0.135 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.335100e-01 | 0.135 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.424112e-01 | 0.129 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.424112e-01 | 0.129 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.424112e-01 | 0.129 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.424112e-01 | 0.129 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.424112e-01 | 0.129 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.424112e-01 | 0.129 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.424112e-01 | 0.129 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.438009e-01 | 0.129 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.516714e-01 | 0.124 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.520823e-01 | 0.124 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.527405e-01 | 0.123 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.527405e-01 | 0.123 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.560252e-01 | 0.121 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 7.560252e-01 | 0.121 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.562788e-01 | 0.121 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.625109e-01 | 0.118 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.633629e-01 | 0.117 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.633653e-01 | 0.117 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.689204e-01 | 0.114 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.689204e-01 | 0.114 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 7.689204e-01 | 0.114 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.720936e-01 | 0.112 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.726489e-01 | 0.112 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.726489e-01 | 0.112 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.811348e-01 | 0.107 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.811348e-01 | 0.107 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.811348e-01 | 0.107 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.811348e-01 | 0.107 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.811348e-01 | 0.107 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.816153e-01 | 0.107 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.816153e-01 | 0.107 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.816153e-01 | 0.107 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.816153e-01 | 0.107 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.826297e-01 | 0.106 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.836624e-01 | 0.106 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 7.836624e-01 | 0.106 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.902698e-01 | 0.102 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.902698e-01 | 0.102 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.902698e-01 | 0.102 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.923202e-01 | 0.101 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.927043e-01 | 0.101 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.927043e-01 | 0.101 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.927043e-01 | 0.101 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.927043e-01 | 0.101 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.927043e-01 | 0.101 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.927043e-01 | 0.101 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.927043e-01 | 0.101 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.964080e-01 | 0.099 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.986204e-01 | 0.098 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.986204e-01 | 0.098 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.011964e-01 | 0.096 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.036628e-01 | 0.095 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.036628e-01 | 0.095 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.036628e-01 | 0.095 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.047438e-01 | 0.094 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.066750e-01 | 0.093 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.066750e-01 | 0.093 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.067691e-01 | 0.093 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 8.079659e-01 | 0.093 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.140427e-01 | 0.089 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 8.140427e-01 | 0.089 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.140427e-01 | 0.089 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.145400e-01 | 0.089 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.209222e-01 | 0.086 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.219279e-01 | 0.085 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 8.219279e-01 | 0.085 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.238744e-01 | 0.084 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.238744e-01 | 0.084 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.238744e-01 | 0.084 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 8.238744e-01 | 0.084 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.244519e-01 | 0.084 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 8.291420e-01 | 0.081 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.331869e-01 | 0.079 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.331869e-01 | 0.079 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.331869e-01 | 0.079 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.331869e-01 | 0.079 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.331869e-01 | 0.079 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.331869e-01 | 0.079 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.331869e-01 | 0.079 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.420075e-01 | 0.075 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.420075e-01 | 0.075 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.420075e-01 | 0.075 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.420075e-01 | 0.075 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.420075e-01 | 0.075 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.420075e-01 | 0.075 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.437058e-01 | 0.074 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.446083e-01 | 0.073 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 8.464296e-01 | 0.072 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.500880e-01 | 0.071 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.503622e-01 | 0.070 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.503622e-01 | 0.070 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.503622e-01 | 0.070 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.503622e-01 | 0.070 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.503622e-01 | 0.070 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.503622e-01 | 0.070 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.525531e-01 | 0.069 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.525531e-01 | 0.069 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.525531e-01 | 0.069 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.582756e-01 | 0.066 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.582756e-01 | 0.066 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.606212e-01 | 0.065 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.614011e-01 | 0.065 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.614011e-01 | 0.065 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.657709e-01 | 0.063 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.657709e-01 | 0.063 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.657709e-01 | 0.063 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.728703e-01 | 0.059 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.779783e-01 | 0.057 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.779783e-01 | 0.057 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.779783e-01 | 0.057 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.795946e-01 | 0.056 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.795946e-01 | 0.056 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 8.830845e-01 | 0.054 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.859636e-01 | 0.053 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.859636e-01 | 0.053 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.902603e-01 | 0.050 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.902603e-01 | 0.050 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.919961e-01 | 0.050 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.919961e-01 | 0.050 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.919961e-01 | 0.050 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 8.919961e-01 | 0.050 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.919961e-01 | 0.050 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.927085e-01 | 0.049 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.931938e-01 | 0.049 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 8.966480e-01 | 0.047 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.972396e-01 | 0.047 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.977098e-01 | 0.047 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 8.977098e-01 | 0.047 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.978630e-01 | 0.047 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.015919e-01 | 0.045 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.031216e-01 | 0.044 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.031216e-01 | 0.044 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.031216e-01 | 0.044 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.082474e-01 | 0.042 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.082474e-01 | 0.042 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.082474e-01 | 0.042 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.111789e-01 | 0.040 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.131022e-01 | 0.039 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.131022e-01 | 0.039 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.131022e-01 | 0.039 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.131022e-01 | 0.039 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.135278e-01 | 0.039 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.136381e-01 | 0.039 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.136381e-01 | 0.039 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.177005e-01 | 0.037 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.177005e-01 | 0.037 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.204648e-01 | 0.036 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.220557e-01 | 0.035 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.220557e-01 | 0.035 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.220557e-01 | 0.035 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.236580e-01 | 0.034 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.247033e-01 | 0.034 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.261806e-01 | 0.033 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.261806e-01 | 0.033 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.275565e-01 | 0.033 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.300875e-01 | 0.031 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.302590e-01 | 0.031 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.306897e-01 | 0.031 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.336944e-01 | 0.030 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.337879e-01 | 0.030 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.337879e-01 | 0.030 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.337879e-01 | 0.030 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.372926e-01 | 0.028 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.372926e-01 | 0.028 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.393375e-01 | 0.027 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.406120e-01 | 0.027 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.406120e-01 | 0.027 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.467336e-01 | 0.024 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.469544e-01 | 0.024 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.490610e-01 | 0.023 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.495537e-01 | 0.022 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.515164e-01 | 0.022 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.522247e-01 | 0.021 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.547545e-01 | 0.020 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.578841e-01 | 0.019 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.589410e-01 | 0.018 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.594196e-01 | 0.018 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.615688e-01 | 0.017 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.636042e-01 | 0.016 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.647073e-01 | 0.016 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.655320e-01 | 0.015 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.672124e-01 | 0.014 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.673578e-01 | 0.014 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.673578e-01 | 0.014 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.707246e-01 | 0.013 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.707246e-01 | 0.013 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.719604e-01 | 0.012 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.737446e-01 | 0.012 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.744114e-01 | 0.011 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.751357e-01 | 0.011 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.755675e-01 | 0.011 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.764533e-01 | 0.010 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.764533e-01 | 0.010 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.766730e-01 | 0.010 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.771247e-01 | 0.010 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.777011e-01 | 0.010 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.781625e-01 | 0.010 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.781625e-01 | 0.010 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.789587e-01 | 0.009 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.795515e-01 | 0.009 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.797067e-01 | 0.009 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.806303e-01 | 0.008 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.815597e-01 | 0.008 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.817894e-01 | 0.008 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.828615e-01 | 0.008 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.833331e-01 | 0.007 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.843349e-01 | 0.007 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.855769e-01 | 0.006 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.857449e-01 | 0.006 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.858688e-01 | 0.006 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.862117e-01 | 0.006 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.863173e-01 | 0.006 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.863417e-01 | 0.006 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.863417e-01 | 0.006 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.863417e-01 | 0.006 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.863417e-01 | 0.006 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.870678e-01 | 0.006 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.884013e-01 | 0.005 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.899042e-01 | 0.004 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.908831e-01 | 0.004 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.911679e-01 | 0.004 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.920802e-01 | 0.003 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.924107e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.928169e-01 | 0.003 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.931813e-01 | 0.003 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.932751e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.934726e-01 | 0.003 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.937781e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.942900e-01 | 0.002 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.955863e-01 | 0.002 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.959285e-01 | 0.002 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.965052e-01 | 0.002 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.969846e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.981554e-01 | 0.001 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.981847e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.983656e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.987505e-01 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.988646e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.989303e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.989515e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.990237e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.993962e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.994238e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.996665e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.998245e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.999053e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999280e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999677e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999818e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999845e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999939e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999988e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999998e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999998e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |